Shionogi’s COVID-19 Treatment Rapidly Lowered Virus Counts

Shionogi’s investigative COVID-19 therapy is showing some promise in early laboratory studies, rapidly clearing viral levels and decreasing the period of active shedding, the company reported at the European Congress of Clinical Microbiology and Infectious Diseases.
Source: Drug Industry Daily